ARCHIVES

Medicare Should Pay Routine Care For Patients in Trials: IOM.

This article is from The Cancer Letter archive.

Vol. 26 No. 01 | January 7, 2000

Download PDF Visit The Full Archive

Related Articles

FDA Approves Iressa For Third-Line Treatment Of Non-Small Cell Lung Cancer

May 9, 2003

Funding opportunities listed.

October 15, 2004

For ADT Reduced Use

November 5, 2010

In Brief: Kennedy To Stay On Health Committee; Animal Research Bills Probably Dead For This Congress

December 10, 1982

European Agency Recommends Transfusions Over ESAs For Cancer Patients With Longer Life Expectancy.

June 27, 2008

ACS Endorses Clinton Health Care Reform, Wit qualifications

March 11, 1994